Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Mol Neurobiol ; 31(1-3): 169-83, 2005.
Article in English | MEDLINE | ID: mdl-15953819

ABSTRACT

In the mammalian nervous system, P2 nucleotide receptors mediate neurotransmission, release of proinflammatory cytokines, and reactive astrogliosis. Extracellular nucleotides activate multiple P2 receptors in neurons and glial cells, including G protein-coupled P2Y receptors and P2X receptors, which are ligand-gated ion channels. In glial cells, the P2Y2 receptor subtype, distinguished by its ability to be equipotently activated by ATP and UTP, is coupled to pro-inflammatory signaling pathways. In situ hybridization studies with rodent brain slices indicate that P2Y2 receptors are expressed primarily in the hippocampus and cerebellum. Astrocytes express several P2 receptor subtypes, including P2Y2 receptors whose activation stimulates cell proliferation and migration. P2Y2 receptors, via an RGD (Arg-Gly-Asp) motif in their first extracellular loop, bind to alphavbeta3/beta5 integrins, whereupon P2Y2 receptor activation stimulates integrin signaling pathways that regulate cytoskeletal reorganization and cell motility. The C-terminus of the P2Y2 receptor contains two Src-homology-3 (SH3)-binding domains that upon receptor activation, promote association with Src and transactivation of growth factor receptors. Together, our results indicate that P2Y2 receptors complex with both integrins and growth factor receptors to activate multiple signaling pathways. Thus, P2Y2 receptors present novel targets to control reactive astrogliosis in neurodegenerative diseases.


Subject(s)
Astrocytes/pathology , Cell Proliferation , Receptors, Purinergic P2/genetics , Signal Transduction/physiology , Amino Acid Sequence/genetics , Animals , Astrocytes/metabolism , Humans , Inflammation , Molecular Sequence Data , Receptors, Purinergic P2/chemistry , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2Y2
3.
Arterioscler Thromb Vasc Biol ; 20(8): 1896-902, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10938009

ABSTRACT

Positioning a silicone collar around the rabbit carotid artery induces a smooth muscle cell-rich intimal thickening. We investigated the localization of inducible nitric oxide synthase (iNOS) during thickening of the intima, the effect of iNOS inhibition on intimal thickness, and the effect of oxidized LDL (ox-LDL) on iNOS expression in the vessel wall. Collars were positioned for 18 hours or for 3, 7, or 14 days. Arterial cross sections were immunostained for iNOS, including naïve, sham-operated, and carotid arteries in which ox-LDL had been infused locally for 14 days. Furthermore, collars were connected to osmotic minipumps for local delivery (5 microL. h(-1), 14 days, n=12) of saline or the iNOS inhibitor L-N(6)-(1-iminoethyl)-lysine-HCl (L-NIL, 10 mmol/L). In the adventitia and the periadventitial granulation tissue of collared arteries, iNOS-positive macrophages and T lymphocytes were present from 18 hours onward. The media and intima were negative for iNOS. Reverse transcription-polymerase chain reaction revealed iNOS mRNA in collared but not in sham-operated arteries. Local inhibition of iNOS doubled the intimal thickness and decreased nitrotyrosine staining. Ox-LDL-treated arteries, which had a thicker intima, showed a pronounced influx of macrophages and T lymphocytes in all layers of the vessel wall, accompanied by iNOS expression in a subpopulation of these cells. Our study indicates that iNOS was not induced in intimal thickenings predominantly consisting of smooth muscle cells. However, iNOS was expressed in (peri)adventitial tissue and counteracted the progression of intimal thickening. Ox-LDL treatment was accompanied by an abundant influx of iNOS-positive macrophages and T lymphocytes in the vessel, but this could not prevent the progression of intimal thickening.


Subject(s)
Carotid Arteries/enzymology , Gene Expression , Nitric Oxide Synthase/genetics , Animals , Antigens, CD/analysis , Antigens, Differentiation, Myelomonocytic/analysis , Blood Pressure , Body Weight , Carotid Arteries/anatomy & histology , Enzyme Inhibitors/pharmacology , Immunohistochemistry , Leukosialin , Macrophages/enzymology , Male , Nitric Oxide Synthase/analysis , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase Type II , RNA, Messenger/analysis , Rabbits , Reverse Transcriptase Polymerase Chain Reaction , Sialoglycoproteins/analysis , T-Lymphocytes/enzymology , Tyrosine/analogs & derivatives , Tyrosine/analysis
4.
Dakar Med ; 43(1): 21-4, 1998.
Article in French | MEDLINE | ID: mdl-9827149

ABSTRACT

Sickle hemoglobinopathies are frequent in black population. Double heterozygous SC gives less general symptoms but ocular complications are very common. Fluorescein angiography of 20 cases are reported. All the patients had hemoglobin electrophoresis showing double heterozygous SC. Clinical investigations included fundus examination and fluorescein angiography. Laser treatment or cryotherapy were realised regarding lesions features. Vascular retinal complications were found in 75% of cases, including vitreous hemorrhage (10% of cases). There was no correlation between fundus examination and fluorescein angiography. Fluorescein angiography is useful for early diagnosis and allows preventive laser treatment.


Subject(s)
Hemoglobin C Disease/complications , Sickle Cell Trait/complications , Vitreoretinopathy, Proliferative/etiology , Vitreous Hemorrhage/etiology , Adolescent , Adult , Child , Cryotherapy , Female , Fluorescein Angiography , Hemoglobin C Disease/genetics , Heterozygote , Humans , Laser Coagulation , Male , Radiography , Retinal Diseases/diagnostic imaging , Retinal Diseases/etiology , Retinal Diseases/therapy , Retinal Vessels/pathology , Sickle Cell Trait/genetics , Vitreoretinopathy, Proliferative/diagnostic imaging , Vitreoretinopathy, Proliferative/therapy , Vitreous Hemorrhage/diagnostic imaging , Vitreous Hemorrhage/therapy
5.
Arterioscler Thromb Vasc Biol ; 17(12): 3602-10, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9437211

ABSTRACT

Extracellular nucleotides, particularly ATP, are involved in the modulation of arterial vasomotricity via P2 purinoceptors present on smooth muscle and endothelial cells. These nucleotides could also be implicated in the smooth muscle cell hyperplasia observed in intimal lesions. In this study, we tried to define the potential role of the P2Y2 (P2u) purinoceptor by studying its expression in normal and balloon-injured rat aortas. The cloning of a rat P2Y2 cDNA from a rat smooth muscle cell cDNA library made it possible to study P2Y2 expression both by Northern blot and in situ hybridization. Northern blot experiments indicated that P2Y2 mRNA was present in rat medial aortic smooth muscle and in cultured rat aortic smooth muscle cells. In situ hybridization indicated that P2Y2 mRNA was present in endothelial cells of the intima and in some smooth muscle cells scattered throughout the media of adult rat aortas, while almost all medial smooth muscle cells of rat embryo aorta expressed this receptor. In contrast with adult aortic media, the majority of neointimal smooth muscle cells found in aortic intimal lesions either 8 or 20 days after balloon injury were positive for P2Y2 mRNA. Moreover, a subpopulation of neointimal cells localized at the luminal surface could be identified by a higher P2Y2 expression than the underlying neointimal smooth muscle cells. These data showing a strong expression of the P2Y2 purinoceptor in the neointima of injured arteries suggest that extracellular nucleotides may be involved, via this receptor, in the intimal hyperplasia and/or chronic constriction observed at the lesion site, and consequently in the restenotic process.


Subject(s)
Aorta/injuries , Receptors, Purinergic P2/metabolism , Tunica Intima/metabolism , Amino Acid Sequence , Angioplasty, Balloon/adverse effects , Animals , Aorta/embryology , Aorta/metabolism , Base Sequence , Cloning, Molecular , DNA, Complementary , Gene Expression , In Situ Hybridization , Male , Molecular Sequence Data , Muscle, Smooth, Vascular/metabolism , Rats , Rats, Wistar , Receptors, Purinergic P2Y2
6.
J Cell Physiol ; 166(1): 57-65, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8557776

ABSTRACT

mRNA of the P2u purinoceptor (or nucleotide receptor) is detected both by polymerase chain reaction or Northern blot analyses in cultured aortic smooth muscle cells. When added to the culture medium of these cells, UTP, a specific ligand of the P2u receptor, induces an increased expression of both immediate-early and delayed-early cell cycle-dependent genes. This induction demonstrates similar features (kinetics, concentration dependence) to those obtained after stimulation of aortic smooth cells by exogenous ATP, a common ligand for most P2 purinoceptors. In contrast, 2-methylthioATP, a preferential ligand for P2y purinoceptors, induces only a significant increase of immediate-early genes but not of delayed-early genes. Moreover, the 2-methylthioATP-induced responses (c-fos mRNA increase, free intracellular calcium transient) are lower than those induced by ATP or UTP and are complementary to those of UTP. These results demonstrate that functional P2u receptors are present on cultured aortic smooth muscle cells and suggest that the bulk of responses induced by extracellular ATP on cell cycle progression are mediated via P2u purinoceptors, a hypothesis confirmed by cytofluorometric studies. Since some ATP- or UTP-induced genes code for chemotactic proteins (monocyte chemoattractant protein-1 and osteopontin), this study suggests that these nucleotides may contribute to vascular or blood cell migration and proliferation and consequently to the genesis of arterial diseases.


Subject(s)
Cell Cycle/physiology , Muscle, Smooth, Vascular/cytology , Receptors, Cell Surface/physiology , Adenosine Triphosphate/physiology , Animals , Aorta/cytology , Base Sequence , Calcium/metabolism , Gene Expression/physiology , Molecular Sequence Data , Muscle, Smooth, Vascular/ultrastructure , Proto-Oncogene Proteins c-fos/genetics , RNA, Messenger/metabolism , Rats , Uridine Diphosphate/metabolism , Uridine Diphosphate/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...